Literature DB >> 11495355

Multiple forms of phosphatase from human brain: isolation and partial characterization of affi-gel blue nonbinding phosphatase activities.

L Y Cheng1, J Z Wang, C X Gong, J J Pei, T Zaidi, I Grundke-Iqbal, K Iqbal.   

Abstract

Phosphatases extracted from a human brain were resolved into two main groups, namely affi-gel blue-binding phosphatases and affi-gel blue-nonbinding phosphatases. Affi-gel blue binding phosphatases were further separated into four different phosphatase activities, designated P1-P4, and described previously. In the present study we describe the affi-gel blue-nonbinding phosphatases which were separated into seven different phosphatase activities, designated P5-P11 by poly-(L-lysine)-agarose and aminohexyl Sepharose 4B chromatographies. These seven phosphatase activities were active toward nonprotein phosphoester. P7-P11 and to some extent P5 could also dephosphorylate a phosphoprotein. They displayed different enzyme kinetics. On the basis of activity peak, the apparent molecular mass as estimated by Sephadex G-200 column chromatography for P5 was 49 kDa; P6, 32 kDa; P7, 150 kDa; P8, 250 kDa; P9, 165 kDa; P10, 90 kDa and P11, 165 kDa. Immunoblot analysis indicated that P8-P11 may belong to PP2B family, whereas P7 may associate with PP2A. The phosphatases P7-P11 were found to be effective in the dephosphorylation of Alzheimer's disease abnormally hyperphosphorylated tau. The resulting dephosphorylated tau regained its activity in promoting the microtubule assembly, suggesting that P7-P11 might regulate the phosphorylation of tau protein in the brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495355     DOI: 10.1023/a:1010963401453

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Protein phosphatase inhibitor-1 and inhibitor-2 from rabbit skeletal muscle.

Authors:  P Cohen; J G Foulkes; C F Holmes; G A Nimmo; N K Tonks
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

2.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease.

Authors:  W K Liu; W T Moore; R T Williams; F L Hall; S H Yen
Journal:  J Neurosci Res       Date:  1993-02-15       Impact factor: 4.164

5.  Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

Authors:  A C Alonso; I Grundke-Iqbal; K Iqbal
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

Review 6.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

7.  Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.

Authors:  J Z Wang; C X Gong; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

8.  Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.

Authors:  E M Mandelkow; G Drewes; J Biernat; N Gustke; J Van Lint; J R Vandenheede; E Mandelkow
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

9.  Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases.

Authors:  T J Singh; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  1995-01-16       Impact factor: 4.124

10.  Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.

Authors:  C X Gong; I Grundke-Iqbal; K Iqbal
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

View more
  4 in total

1.  Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1.

Authors:  Abdur Rahman; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Neurochem Res       Date:  2005-02       Impact factor: 3.996

Review 2.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

Review 3.  Developing pharmacological therapies for Alzheimer disease.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  Cell Mol Life Sci       Date:  2007-09       Impact factor: 9.261

Review 4.  Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  J Cell Mol Med       Date:  2007-01-09       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.